| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.6 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.6 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |